Copyright
©The Author(s) 2023.
World J Gastroenterol. Nov 7, 2023; 29(41): 5668-5682
Published online Nov 7, 2023. doi: 10.3748/wjg.v29.i41.5668
Published online Nov 7, 2023. doi: 10.3748/wjg.v29.i41.5668
Table 1 Sample characteristics concerning the type of inflammatory bowel disease
Variable | Crohn’s disease(n = 92) | Ulcerative colitis(n = 127) | P value1 |
Age | 43.5 (29-53) | 41 (30-55) | 0.871 |
BMI | 23.8 (20.8-26.4) | 23.8 (21.4-25.9) | 0.787 |
Gender | 0.1572 | ||
Male | 44 (47.8%) | 73 (57.5%) | |
Female | 48 (52.5%) | 54 (42.5%) | |
Education | 0.192 | ||
Primary school | 32 (24.8%) | 27 (21.3%) | |
Secondary school | 52 (56.5%) | 78 (61.4%) | |
Degree | 8 (8.7%) | 22 (17.3%) | |
Job | 0.009 | ||
Unemployed | 56 (60.9%) | 51 (40.2%) | |
Employee | 16 (17.4%) | 38 (29.9%) | |
Entrepreneur | 8 (8.7%) | 16 (12.6%) | |
Worker | 4 (4.3%) | 7 (5.5%) | |
Student | 8 (8.7%) | 15 (11.8%) | |
Smoking status | 0.003 | ||
Active smoker | 16 (17.4%) | 20 (15.7%) | |
Past smoker | 32 (34.8%) | 16 (12.6%) | |
Non-smoker | 44 (47.8%) | 91 (71.7%) | |
Alcohol consumer | 0.8272 | ||
Yes | 8 (8.7%) | 10 (7.9%) | |
No | 84 (91.4%) | 117 (92.1%) | |
Comorbidity | 0.256 | ||
Diabetes | 8 (8.7%) | 4 (3.1%) | |
Hypertension | 20 (21.7%) | 10 (7.9%) | |
Recurrent UTI | 2 (2.2%) | 4 (3.1%) | |
Chronic renal failure | 1 (1.1%) | 2 (1.6%) | |
Nephrolithiasis | 3 (3.3%) | 1 (0.8%) | |
Asthma | 3 (3.3%) | - | |
COPD | 2 (2.2%) | 1 (0.8%) | |
Previous pneumonia | 1 (1.1%) | 1 (0.8%) | |
Dyslipidaemia | 12 (13%) | 35 (27.6%) | |
Arthritis | 32 (34.8%) | 34 (26.8%) | |
Hashimoto’s thyroiditis | 7 (7.6%) | 15 (11.8%) | |
Partner | 0.3222 | ||
Yes | 68 (73.9%) | 86 (67.7%) | |
No | 24 (26.1%) | 41 (32.3%) | |
Biologics (yes) | 76 (82.6%) | 78 (61.4%) | 0.0012 |
Steroids (yes) | 4 (4.3%) | 8 (6.3%) | 0.5312 |
- Citation: Gravina AG, Pellegrino R, Durante T, Palladino G, D’Onofrio R, Mammone S, Arboretto G, Auletta S, Imperio G, Ventura A, Romeo M, Federico A. Inflammatory bowel diseases patients suffer from significant low levels and barriers to physical activity: The “BE-FIT-IBD” study. World J Gastroenterol 2023; 29(41): 5668-5682
- URL: https://www.wjgnet.com/1007-9327/full/v29/i41/5668.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i41.5668